Previous 10 | Next 10 |
home / stock / bldr / bldr articles
Builders FirstSource (NYSE:BLDR) has outperformed the market over the past 15 years by 13.64% on an annualized basis producing an average annual re...
The stock market is up solidly this year, thanks to expectations of rate cuts by the Federal Reserve amid easing inflationary pressure, strong corp...
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these b...
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? GameStop Corporation (NYSE:GME) shares lost 29....
Builders FirstSource (NYSE:BLDR) has outperformed the market over the past 10 years by 25.61% on an annualized basis producing an average annual re...
These 10 large-cap stocks were the worst performers last week. Are they in your portfolio? EPAM Systems, Inc. (NYSE:EPAM) shares tumbled...
Jim Cramer, the host of CNBC’s “Mad Money,” has warned investors about the current state of the economy and suggested strategies ...
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adj...
Builders FirstSource, Inc. (NYSE:BLDR) shares are trading lower following the first quarter earnings result. The company reported adjuste...
News, Short Squeeze, Breakout and More Instantly...
Builders FirstSource Inc. Company Name:
BLDR Stock Symbol:
NASDAQ Market:
Builders FirstSource Inc. Website:
Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource” or the "Company") will host a conference call and webcast on Tuesday, August 6, 2024, to discuss the Company’s financial results and other business matters. The teleconference will begin at 8:00 a.m. Central Time...
2024-06-17 09:30:06 ET Zelman analyst issues NEUTRAL recommendation for BLDR on June 17, 2024 07:46AM ET. The previous analyst recommendation was Buy. BLDR was trading at $149.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...